Waiting at .016, page-30

Yes a deal or offer could come at anytime.

Whilst with more run of the mill drugs big pharma wants to see successful phase 2 results, with this type of game-changing technology deals are done far earlier.

I guess if big pharma waits until a successful phase 2 with imu then the price and competition is astronomical.

Now there's more proof of safety and evidence of action - so it might just push somebody to have a nibble.

For Genentech it would make great sense imho. A Herceptin 2.0 - with a long new ip date. But imu have a whole pipeline too.

Today was a big step down what could be a very profitable road. Ignore the share price - focus on the destination.

cheers